Champions Oncology Says New Xenograft Models Will Aid Prostate Cancer Research
News
Champions Oncology has added new cohorts of patient-derived xenograft (PDX) models to its TumorBank, expanding the company’s product line in castrate-resistant prostate cancer (CRPC) and other ailments. The new PDX models ... Read more